ImmuCell Corporation Additional Paid in Capital, Common Stock
ImmuCell Corporation (ICCC) had Additional Paid in Capital, Common Stock of $41.97 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $41.97M.
- 2026-03-31: Additional Paid in Capital, Common Stock $41.68M.
- 2025-12-31: Additional Paid in Capital, Common Stock $41.48M.
- 2025-09-30: Additional Paid in Capital, Common Stock $41.38M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $41.97M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $41.68M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $41.48M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $41.38M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $41.30M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $40.94M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $40.92M 10-K · filed 2026-03-30 |
| 2024-09-30 | $40.34M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $36.78M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $36.44M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $36.36M 10-K · filed 2025-03-28 |
| 2023-09-30 | $36.25M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $35.98M 10-K · filed 2024-04-01 |
| 2016-03-31 | $15.36M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $10.15M 10-Q · filed 2016-05-11 |
| 2015-09-30 | $10.14M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $10.08M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $10.05M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $10.04M 10-K · filed 2016-03-25 |
| 2014-09-30 | $10.03M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $10.03M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $10.02M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $10.01M 10-K · filed 2015-03-26 |
| 2013-09-30 | $10.00M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $9.99M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $9.98M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $9.97M 10-K · filed 2014-03-26 |
| 2012-09-30 | $9.96M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $9.95M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $9.95M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $9.91M 10-K · filed 2013-03-28 |
| 2011-09-30 | $9.90M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $9.82M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $9.78M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |